Cytolytic effects of the complement cleavage product, C3a

Area of Science:

• Immunology
• Complement System
• Cancer Biology

Background:

• The complement system is a crucial part of innate immunity.
• C3a is a potent anaphylatoxin and a cleavage product of the third complement component (C3).

Purpose of the Study:

• To investigate the cytotoxic effects of purified C3a on various human and mouse tumor cell types.
• To compare the sensitivity of tumor cells versus normal lymphocytes to C3a-mediated lysis.
• To explore the potential role of C3a in anti-tumor immunity.

Main Methods:

• Incubation of purified C3a with different human and mouse cell lines, including tumor cells and normal lymphocytes.
• Assessment of cell lysis following C3a treatment.
• Control experiments using C3 and C3b to evaluate their lytic activity.

Main Results:

• Low concentrations of purified C3a induced significant lysis in all tested tumor cell types.
• Normal human lymphocytes exhibited relative resistance to C3a-induced lysis.
• Neither C3 nor C3b demonstrated any significant cell lysis under the experimental conditions.

Conclusions:

• C3a possesses direct cytotoxic effects specifically against tumor cells.
• The differential sensitivity of tumor cells and normal lymphocytes to C3a suggests a potential therapeutic window.
• C3a may play a significant role in the immune response against tumors.